The Financial Times reported in November that Unilever ( UL) axed a plan to sell its €15bn ice-cream business to private ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

The fund invests in sectors such as nuclear solutions, UAV automation, marine technologies, among others and is managed by ...

Mitali Mukherjee offers an insightful analysis of the slowdown currently ailing India's startup ecosystem, not just in terms ...